For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonist use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use.

Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

While the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...

Robard Corporation, a trusted leader in scientifically designed nutrition products for the medical weight management community since 1976, today announced the reformulation of Biocare — its ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...